Isomorphic Labs in talks to raise $5B
Isomorphic Labs is reportedly in talks to raise $5 billion at a $50 billion valuation, according to Bloomberg sources. Demis Hassabis expects the DeepMind spinout's first clinical trials to begin by the end of December, utilizing its Isomorphic Drug Design Engine to predict molecular structures. Open article →
- Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports
- Demis Hassabis is raising $5B at a $50B valuation for a company with ZERO drugs in human trials ...
- Isomorphic Labs: Hassabis‘ Pharma AI Set for 5 Billion Dollar Mega-Round Without a Single Drug Tested in Humans
- Bloomberg: Isomorphic Labs, The Alphabet company spun out of Google DeepMind is negotiating a rou...
- Isomorphic Labs in Talks for About $5 Billion in Funding